Here’s a fact that trips up even careful researchers: a peptide can show 98% purity on its certificate of analysis and still not be the compound printed on the label. Those two numbers—purity and identity—answer completely different questions, and confusing them can quietly undermine an entire study.
Two Questions, Not One
It helps to separate the concepts precisely. Purity asks: how clean is this sample? It quantifies what fraction of the material is your target species versus everything else—residual solvents, salts, deletion products, and other contaminants. Identity asks a more fundamental question: is this actually the correct peptide sequence? Purity tells you how much of the dominant species is present; identity tells you whether that species is the molecule you intended to make.
The two can diverge in ways that matter. A sample can be exquisitely clean—a single sharp peak, 98% or higher—and still be dominated by the wrong molecule. High purity of the wrong compound is still the wrong compound.
Where Synthesis Goes Sideways
To understand how this happens, look at how peptides are built. Solid-phase peptide synthesis assembles a chain one amino acid at a time, cycle after cycle. Each coupling step is efficient but not perfect. When a coupling fails, the chain can come up short—a truncated sequence missing one or more residues. Deletion sequences, incomplete deprotection, side-chain modifications, and racemization can all introduce closely related but incorrect species.
Some of these byproducts are so structurally similar to the target that they co-elute or sit right beside it on a chromatogram. A truncated peptide missing a single residue may differ from the target by only a small fraction of its total mass—easy to miss if you’re only looking at how clean the peak appears. That’s the trap: a chromatography method optimized to report purity may not resolve, or even flag, a sequence that’s fundamentally wrong.
The Documentation That Actually Answers Both Questions
This is why rigorous characterization uses two complementary analytical tools, each answering its own question:
- High-Performance Liquid Chromatography (HPLC) separates the components of a sample and reports purity—the relative abundance of the main peak against impurities. It tells you how clean the sample is.
- Mass Spectrometry (MS) measures the molecular mass of the species present and confirms identity. By matching the observed mass to the theoretical mass of the intended sequence, MS verifies you’re looking at the right molecule—and can expose truncations or deletions that add or subtract residues.
Used together, HPLC and MS answer both questions: how clean and what is it. A certificate of analysis that reports only one leaves a blind spot.
Why This Matters for Researchers
In a research setting, the integrity of every downstream result rests on knowing exactly what compound was in the vial. An unverified or misidentified peptide introduces a silent variable: experiments become irreproducible, structure–activity relationships get muddied, and conclusions may be built on a molecule that was never actually tested. Purity absolutely matters—but identity comes first. A clean sample of the wrong sequence is worse than useless, because it looks trustworthy.
The practical takeaway for anyone sourcing research peptides is simple: insist on documentation that reports both. Look for HPLC data to establish purity and mass spectrometry data to confirm molecular identity. When both are in hand, you know not just how clean your material is, but that it’s genuinely the compound your protocol calls for.
All products and information referenced are strictly for research use only (RUO). They are not intended for human or veterinary use, diagnostic procedures, or therapeutic applications.